All posts by: Michael Zand

About Michael Zand

Novel leukemia treatment could be 1st US gene therapy – Chicago Daily Herald

Continue reading

2017-07-13 NEWS

Chicago Daily Herald

Novel leukemia treatment could be 1st US gene therapy
Chicago Daily Herald
CAR-T therapy starts with filtering key immune cells called T cells from a patient’s blood. In a lab, a gene is then inserted into the T cells that prompts them to grow a receptor that targets a special marker found on some blood cancer cells. Millions

Continue reading

2017-07-13 NEWS

Chicago Daily Herald

Novel leukemia treatment could be 1st US gene therapy
Chicago Daily Herald
CAR-T therapy starts with filtering key immune cells called T cells from a patient’s blood. In a lab, a gene is then inserted into the T cells that prompts them to grow a receptor that targets a special marker found on some blood cancer cells. Millions

Continue reading

2017-07-13 NEWS

USA TODAY

‘Major advance’: Leukemia treatment could be first US gene therapy
USA TODAY
A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S.. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of …
Gene therapy to kill cancer moves a step closer to marketCNET
Pioneering cancer gene therapy by Novartis backed by US panelCNBC
Novel leukemia treatment could be 1st US gene therapyABC News
CBS News –Reuters –Sun Sentinel –FDA
all 101 news articles »
Continue reading

2017-07-13 NEWS

USA TODAY

‘Major advance’: Leukemia treatment could be first US gene therapy
USA TODAY
A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S.. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of …
Gene therapy to kill cancer moves a step closer to marketCNET
Pioneering cancer gene therapy by Novartis backed by US panelCNBC
Novel leukemia treatment could be 1st US gene therapyABC News
CBS News –Reuters –Sun Sentinel –FDA
all 101 news articles »
Continue reading

2017-07-13 NEWS

Local 10

Cancer-fighting immunotherapy recommended for FDA approval
Local 10
A panel of experts voted to endorse the immunotherapy drug, known as tisagenlecleucel, which treats a type of leukemia that is more common among children. Ten committee members voted in favor, and one left early without voting. None voted against.
‘Living Drug’ That Fights Cancer By Harnessing Immune System Clears Key HurdleNPR
Novel cancer treatment wins endorsement of FDA advisersWashington Post
Landmark Novartis Immunotherapy Faces Crucial FDA Hearing WednesdayTheStreet.com
BioWorld Online –Chicago Tribune –New York Times –FDA
all 140 news articles »
Continue reading

2017-07-13 NEWS

Local 10

Cancer-fighting immunotherapy recommended for FDA approval
Local 10
A panel of experts voted to endorse the immunotherapy drug, known as tisagenlecleucel, which treats a type of leukemia that is more common among children. Ten committee members voted in favor, and one left early without voting. None voted against.
‘Living Drug’ That Fights Cancer By Harnessing The Immune System Clears Key HurdleNPR
Novel cancer treatment wins endorsement of FDA advisersWashington Post
Landmark Novartis Immunotherapy Faces Crucial FDA Hearing WednesdayTheStreet.com
BioWorld Online –Markets Insider –The Nation –Novartis
all 86 news articles »